Yüklüyor......
Safety and efficacy of azacitidine in myelodysplastic syndromes
PURPOSE: The clinical efficacy, different dosages, treatment schedules, and safety of azacitidine are reviewed. SUMMARY: Azacitidine is the first drug FDA-approved for the treatment of myelodysplastic syndromes that has demonstrated improvements in overall survival and delaying time to progression t...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2948932/ https://ncbi.nlm.nih.gov/pubmed/20957213 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|